Why Canopy Growth Stock Has Been Very Volatile Lately

Here’s why cannabis investors may want to keep an eye on Canopy Growth (TSX:WEED)(NYSE:CGC) stock right now.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cannabis stocks in Canada have continued to underperform in 2021 from a growth perspective. It appears that the optimism that was there even a few years back for investors in Canopy Growth (TSX:WEED)(NYSE:CGC) stock, among others, has waned.

However, looking specifically at Canopy Growth, this company is one that’s been a volatile one. Two weeks ago, Canopy Growth stock hit levels not seen since September. However, since then, this stock has cooled off substantially, to put it mildly.

Is this volatility set to continue? Let’s discuss.

Potential U.S. legalization boosting the sector

Leading up to the impressive rally in Canopy Growth stock through Nov. 12, investors appeared to be very bullish on the potential for U.S. legalization legislation to be passed. For Canopy Growth, such legalization would open up a massive market that Canopy Growth could certainly benefit from.

After all, this is a company that’s been making partnership deals and looking at ways of entering the U.S. market for some time. Should legalization materialize, the entire cannabis sector would have another catalyst to rely on.

However, this past week, it appears sentiment in this regard is fading. Investors looking at Canada’s cannabis market note annual growth of around 40% for the entire sector. However, the ultimate size of the Canadian market relative to the U.S. means American legalization could be a much bigger catalyst that investors may simply have priced in too early. If this is the case, investors may simply be getting ahead of themselves. At least, this is what many believe is behind the price action with Canopy Growth stock this past week.

Earnings drove volatility with Canopy Growth stock

Additionally, earnings season tends to provide significant volatility for most stocks. For Canopy Growth, this certainly appears to be the case.

The company posted its earnings for the quarter ended September 2022 earlier this month. These earnings generally appeared to disappoint investors, who were hoping for more in the way of growth.

Net revenue came in 3% lower — a surprise for many. Given how rapidly the Canadian cannabis market is growing, posting a revenue decline is a big deal. That said, Canopy Growth was able to narrow its quarterly loss to $16 million, from $96 million a year earlier.

Right now, it appears there aren’t many catalysts that investors can jump on with respect to Canopy Growth stock. This company’s revenue is stagnating. It’s not profitable. And the outlook for U.S. legalization remains dim.

Bottom line 

Canopy Growth stock is one I expect to be volatile, for quite some time. The valuation cannabis stocks have garnered in recent years have really come into focus from investors. I think as the sector matures, these companies will become more stable in this regard. However, that may take time.

Accordingly, those looking at cannabis stocks right now may want to take caution. This is a sector that’s still going through some growing pains. Accordingly, I remain on the sidelines with this sector for the time being.

Should you invest $1,000 in CIBC right now?

Before you buy stock in CIBC, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and CIBC wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »